Latest News about ABBV
Recent news which mentions ABBV
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
3 Stocks That Could Make You Richer in December (and Beyond)
December 02, 2021
From Motley Fool
From Benzinga
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
December 01, 2021
From Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
November 23, 2021
From Benzinga
4 Top Dividend Stocks I'd Buy If I Were About to Retire
November 21, 2021
From Motley Fool
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
1 Dividend Stock to Help You Fight Inflation
November 17, 2021
From Motley Fool
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
November 17, 2021
From Motley Fool
Here’s why tech could be the sweet spot for next year, but this hot sector is a no, says Wells Fargo
November 16, 2021
From MarketWatch
Merck Is a Dividend Play Ready to Get Back in Gear
November 16, 2021
From InvestorPlace
2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash
November 15, 2021
From Motley Fool
5 Long-Term Investments You'll Thank Yourself for Later
November 15, 2021
From Motley Fool
4 Fantastic Dividend Stocks to Buy With Yields of 4% or More
November 14, 2021
From Motley Fool
Believe It or Not, These Stocks Pay You to Own Them
November 13, 2021
From Motley Fool
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
From Benzinga
3 Best Biotech Stocks to Buy in November
November 08, 2021
From Motley Fool
Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income
November 07, 2021
From Motley Fool
Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More
November 06, 2021
From Benzinga
Merck Receives Another Boost for Its Top-Selling Drug
November 04, 2021
From Motley Fool
7 Dividend Aristocrat Stocks That Should Grace Your Portfolio
November 03, 2021
From InvestorPlace
Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs
November 03, 2021
From Benzinga
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
From Motley Fool
Why Teva Pharmaceutical Stock Is Jumping Today
November 02, 2021
From Motley Fool
Healthcare Stocks Subject to Government Policy
November 02, 2021
From Benzinga
California Judge Rules For Drugmakers In Major Opioid Litigation
November 02, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.